-The Indian Express The tragedy of several women dying after undergoing sterilisation operations in the Bilaspur district of Chhattisgarh has once again thrown up uncomfortable questions around India's population programme. Although the cases are being investigated and the exact cause of the deaths has not been ascertained, the incident brings to light the abysmal conditions in which women are compelled to accept government-provided contraception. India is a signatory to an agreement at...
More »SEARCH RESULT
Drug prices to go up as govt bans PET medicine bottles, is ban based on data?
-The News Minute The use of plastic or polyethylene terephthalate (PET) bottles for packaging medicines such as syrups and liquid orals has been banned by the government. Reports say that this ban will lead a price hike for certain drugs meant for children, women and senior citizens. According to a Times of India report SV Veeramani, president, Indian Drug Manufacturers Association (IDMA) confirmed the move, "There would be estimated 25-30% cost increase...
More »Jean Dreze, economist and activist, interviewed by Atmadip Ray
-The Economic Times For one who had worked so closely to frame the world's largest job guarantee programme, known as the Mahatma Gandhi National Rural Employment Guarantee Act, it's not easy to see it succumb to pressure. It's no wonder that economist-cum-activist Jean Dreze will raise his voice against this, along with eminent academics such as Pranab Bardhan and Maitreesh Ghatak. Dreze says corruption related to NREGA and leakages - its...
More »Cancer care goes free for the poor in Kerala -KPM Basheer
-The Hindu Business Line Through the ‘Sukrutham' scheme, the Kerala Government aims to take advanced cancer treatment to the poorest Kerala: "We have two options, medically and emotionally: give up or fight like hell," Lance Armstrong, champion cycle racer, who recovered from advanced testicular cancer once said about his battle against cancer. The American, fortunately, had the money to pay for the extremely expensive treatment. But, for the majority of 1.75 lakh...
More »New hepatitis cure far too costly -Martin Khor
-Asia News Network A controversy is brewing over a new cure for hepatitis C because it is extremely expensive and patients in middle-income countries like Malaysia will find it way beyond their budget. There are an estimated 400,000 Malaysians with hepatitis C, but this is probably a significant under-estimate since many people are not aware that they have the virus. Worldwide, 170 million people live with the hepatitis C virus (HCV), and every...
More »